Puma Biotechnology, Inc.
Pharmaceutical Preparations · Los Angeles, CA, United States
- PrincipalsAlan H AuerbachPresident and CEOMaximo F NouguesChief Financial Officerand 2 more
- CompanyPuma Biotechnology, Inc.Los Angeles, CA, United States
- Phone line+1 (424) 248-6500General business
Puma Biotechnology, Inc. is an SEC-registered Nasdaq-listed company (ticker PBYI) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 4
Chief executive
Alan H AuerbachPresident and CEO
Chair & board
Michael Patrick MillerDirector (Board)
Finance
Maximo F NouguesChief Financial Officer
Everyone else on file (1)
Douglas M HuntOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Alan H Auerbach — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Maximo F Nougues — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Douglas M Hunt — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Michael Patrick Miller — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Mereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capability